These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 3403885

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Hepatolenticular degeneration (Wilson's disease).
    Wis Med J; 1970 Mar; 69(3):105-10. PubMed ID: 5434427
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. [Hepatolenticular degeneration, Wilson's disease. A characteristics case with remission under penicillamine therapy].
    Hansen J, Andersen OS.
    Ugeskr Laeger; 1969 Jul 31; 131(31):1306-9. PubMed ID: 5824791
    [No Abstract] [Full Text] [Related]

  • 47. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
    Sturniolo GC, Mestriner C, Irato P, Albergoni V, Longo G, D'Incà R.
    Am J Gastroenterol; 1999 Feb 31; 94(2):334-8. PubMed ID: 10022625
    [Abstract] [Full Text] [Related]

  • 48. Preparation of triethylenetetramine dihydrochloride for the treatment of Wilson's disease.
    Dixon HB, Gibbs K, Walshe JM.
    Lancet; 1972 Apr 15; 1(7755):853. PubMed ID: 4111619
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Treatment of Wilson's disease (hepatolenticular degeneration) with penicillamine and low-copper diet.
    Goldstein NP, Tauxe WN, McCall JT, Gross JB, Randall RV.
    Trans Am Neurol Assoc; 1969 Apr 15; 94():34-7. PubMed ID: 5374484
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice.
    Hoogenraad TU.
    Brain Dev; 2006 Apr 15; 28(3):141-6. PubMed ID: 16466879
    [Abstract] [Full Text] [Related]

  • 54. [Immunologic studies with the lymphocyte transformation test on the side effects of D-penicillamine therapy in Wilson's disease].
    Storch W, Berger H.
    Z Gesamte Inn Med; 1980 Jul 01; 35(13):567-70. PubMed ID: 7445606
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. [Hepatolenticular degeneration or Wilson's disease. Results of treatment].
    Concours Med; 1965 Apr 24; 87(17):2941-6. PubMed ID: 5317932
    [No Abstract] [Full Text] [Related]

  • 57. [Treatment of Wilson's disease].
    Pépin B, Barraine R.
    Cah Coll Med Hop Paris; 1968 Feb 24; 9(2):184-7. PubMed ID: 5745277
    [No Abstract] [Full Text] [Related]

  • 58. [Therapy and rehabilitation of Wilson's disease (author's transl)].
    Eichner B, Lössner J, Bachmann H, Diessner H, Biesold D, Günther K.
    Folia Clin Int (Barc); 1974 Nov 24; 24(11):776-92. PubMed ID: 4435281
    [No Abstract] [Full Text] [Related]

  • 59. Wilson's disease: clinical management and therapy.
    Brewer GJ, Askari FK.
    J Hepatol; 2005 Nov 24; 42 Suppl(1):S13-21. PubMed ID: 15777568
    [No Abstract] [Full Text] [Related]

  • 60. Letter: Drugs for rare diseases.
    Walshe JM.
    Br Med J; 1975 Sep 20; 3(5985):701-2. PubMed ID: 1174857
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.